They found that in human and mouse breast cancer stem cells, the HMGB1/TLR2 axis promotes NF-κB signaling, production of IL-6 and TGF-β, and activation of STAT3, thereby facilitating self-renewal of CSCs 60. This evidence concerns the gene TLR2 and breast carcinoma.